Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Leiomyoma 1Inflammation 1Frailty 1

Interventions

telapristone acetate 13estradiol, norethindrone drug combination 9elagolix 7Estradiol 7relugolix 6Norethindrone Acetate 5vilaprisan 4ulipristal acetate 4Sugars 3Uterine Myomectomy 2Lidocaine 2Leuprolide 2Letrozole 2ulipristal 1epigallocatechin gallate 1Vitamin B 6 1Uterine Artery Embolization 1Tranexamic Acid 1Therapeutics 1Standard of Care 1Sodium Chloride 1Ropivacaine 1Rocuronium 1Progesterone 1Pregabalin 1Morphine 1Misoprostol 1Mifepristone 1Injections, Subcutaneous 1Ibuprofen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leiomyoma × epigallocatechin gallate × Clear all
NCT04177693 2023-06-05

Pharmacokinetics and Hepatic Safety of EGCG

Yale University

Phase 1 Completed
39 enrolled 18 charts

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡